🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This study is being done because the investigators are trying to understand...
Status
Completed
Location
Mayo Clinic - Saint Marys Hospital
Start Date
2012-07
Trial ID
NCT02421341
Treatments Being Tested
To evaluate the usefulness of chemosensitivity test in evaluating the appro...
Status
Completed
Location
Nagoya University Hospital
Start Date
2006-03
Trial ID
NCT00287755
Treatments Being Tested
There is an increased risk for sleep disordered breathing (SDB), sleep-rela...
Status
Recruiting
Location
John D. Dingell VA Medical Center, Detroit, MI
Start Date
2019-05-02
Trial ID
NCT05589753
Treatments Being Tested
The purpose of this randomized clinical study is to confirm the utility of ...
Status
Withdrawn
Location
Univeristy of Mississippi Medical Center
Start Date
2018-08-01
Trial ID
NCT03632798
Treatments Being Tested
DiaTech is a private company performing patient specific cancer chemosensit...
Status
Completed
Location
Nashville Breast Center
Start Date
2006-09
Trial ID
NCT00243685
Treatments Being Tested
The primary working hypothesis is that preoperative chemo-sensitivity testi...
Status
Completed
Location
Clinique St-Luc Bouge
Start Date
2009-11
Trial ID
NCT00994864
Treatments Being Tested
The purpose of this study is to evaluate the number of circulating tumor ce...
Status
Unknown
Location
Comprehensive Cancer Centers of Nevada
Start Date
2014-04
Trial ID
NCT02123862
This phase II trial studies how well panobinostat, carfilzomib, and dexamet...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2018-02-08
Trial ID
NCT03256045
Treatments Being Tested
2.0 Study Objectives: 2.1 To evaluate the ability of the MiCK assay to pred...
Status
Completed
Location
Southeastern Gynecologic Oncology
Start Date
2006-03
Trial ID
NCT00443196
Treatments Being Tested